Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hypertension Age: Adult |
Dose: Conventional Tablet – Initially, 0.5 mg Frequency: twice daily or three times daily Duration: for 3-7 days Note: thereafter increased to 1 mg twice daily or three times daily for the next 3-7 days; then daily dose increased gradually as determined by blood pressure response; maintenance dosage of Prazosin alone up to 15 mg daily in divided doses; Max: 20 mg/day in divided doses; dosage should be individualized depending on patient tolerance and response |
|
Indication: Hypertension Age: Adult |
Dose: Extended Release Tablet – Initially, 2.5 mg Frequency: once daily Note: dosage may be increased slowly, in general over a 7 to 14 day period, depending on response; maintenance dose may be increased as clinically indicated to 20 mg given in once-daily doses; Max: doses above 20 mg once daily have not been studied; dosage should be individualized depending on patient tolerance and response; hypertensive patients controlled on Prazosin tablets may be switched to extended release at equivalent or nearest higher total daily dose (e.g. 4 mg tablets equivalent to 5 mg extended release once daily) |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not specified Note: Dose reduction needed. |
Administration
- Can be taken with or without food
- Initial dose best with dinner
Side Effect
- Dizziness (10%)
- Drowsiness (8%)
- Headache (8%)
- Weakness (7%)
- Asthenia (6.5%)
- Nausea (5%)
- Edema
- Orthostatic hypotension
- Syncope
- Fever
- Rash
- Abdominal discomfort/pain
- Diarrhea
- Vomiting
- Abnormal liver function tests
- Impotence
- Pancreatitis
- Urinary incontinence
- Rarely
- hypotension may be life-threatening
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Diuretics, Antihypertensive (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, Propranolol, Metoprolol, Atenolol, Carvedilol, Bisoprolol, Nadolol, Amlodipine, Diltiazem, Verapamil, Nifedipine, Nicardipine, Hydrochlorothiazide, Chlorthalidone, Indapamide, Furosemide, Bumetanide, Torsemide, Spironolactone, Amiloride, Triamterene, Prazosin, Doxazosin, Terazosin, Clonidine, Methyldopa, Hydralazine, Minoxidil)
|
Hypotensive effects may be enhanced
|
|
Beta-blockers (Propranolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol, Nadolol, Timolol, Sotalol), Calcium Channel Blockers (Amlodipine, Diltiazem, Verapamil, Nifedipine, Felodipine, Nicardipine, Isradipine)
|
Increased risk of first dose hypotension
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Congestive Heart Failure
|
Can worsen mechanical obstruction
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep away from light and moisture, store below 30° C. Keep away from reach out of the children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.